This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Greenberg: Revisiting Three Much-Talked-About Names

This story has been corrected to reflect the earlier misidentification of an individual. We regret this error

Editor's Note: This article was originally published at 6 a.m. EDT on Real Money on Sept. 7, as part of the NFL Kickoff Open House. Sign up for a free trial of Real Money.

I'm working on a host of names that aren't yet ready for prime time, so let's revisit several oldies but (still!) goodies.

Can Intuitive Surgical Regain Its Cutting Edge?

Intuitive Surgical's (ISRG - Get Report) shares have lost roughly one-quarter of their value after tumbling on surprisingly bad financial results last July. Sales growth tumbled to 7.8%, from 23.4% the previous quarter and 25.7% a year earlier. Most of the blame went to the Da Vinci surgical robot which, for whatever reason, didn't sell anywhere near as well as expected.

Analyst after analyst, caught flat-footed, immediately lowered estimates and/or downgraded their ratings.

One notable exception was Suraj Kalia of Northland Securities, who upgraded Intuitive to Market Perform. But he gets a pass. He had, after all, been the lone bear on the stock, and the quarter was worse than even he had expected.

Given this market, where the heavily shorted and clobbered stocks often miraculously become next week's winners, Kalia wasn't taking any chances. "The stock is down almost $180 (35%) from the time we initiated," he wrote, "hence we believe it is prudent to move to the sidelines for the time being." He quickly added, "That does not mean our long-term concerns are alleviated by any stretch."

William Blair's Ben Andrew also veered from the pack. But, unlike Kalia, he reiterated his Outperform rating in a note that tried to highlight what went right.

Now the most bullish of all analysts, Andrew is more enthusiastic than ever. After he had time to do further research, including an analysis of robot sales and the utilization rate of the robot at hospitals -- and after a meeting with CEO Gary Guthart -- Andrew said in a report Monday that he now believes there may be upside to his own expectations.

As it turns out, his report was issued the same day that First Analysis analyst Greg Chodaczek downgraded Intuitive to Underweight, saying just the opposite. Chodaczek said that he believes "consensus estimates remain overly optimistic" and that he sees "more downside than upside risk to our own below-consensus estimates." Chodaczek adds that he expects "prolonged weakness in the stock as we expect the valuation gradually to reflect a reduced and less-certain growth outlook."
  1 2 3

Herb Greenberg, editor of Herb Greenberg's Reality Check, is a contributor to CNBC. He does not own shares, short or trade shares in an individual corporate security.


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Herb's Tweets

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs